Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
ADC Therapeutics SA secures $86.6 million in Private Equity financing, with participation from Bain Capital Life Sciences and existing investors. This strategic move aims to extend the company's cash runway into 2029.
Amount Raised
$86.6 Million
Round Type
Private Equity
LausanneBiotechnologyHealth CareTherapeuticsInvestors
Description
ADC Therapeutics SA has announced a strategic financial restructuring, which includes a $86.6 million private placement involving both new and existing investors. This financing effort is intended to enhance the company’s capital structure and extend its cash runway. The deal includes participation from Bain Capital Life Sciences among others. The restructuring aims to maximize shareholder value and reduce leverage.
Fundz sees it the moment ADC Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ADC Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.